Exhibit 99.1 INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE FISCAL SECOND QUARTER ENDED DECEMBER 31, 2025 DENVER, CO., February 3, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced financial results for its fiscal second quarter ended December 31, 2025. Full Fiscal Year 2026 ...

Exhibit 99.1 News Release For Immediate Release: February 3, 2026 H&R Block Reports Fiscal 2026 Second Quarter Results — Revenue Increased 11% — — Reaffirms Full Year Outlook — KANSAS CITY, Mo. - H&R Block, Inc. (NYSE: HRB) (the "Company") today released financial results for its fiscal 2026 second quarter ended December 31, 2025. 1 "Across the business, we've made tangible improvements this season, whether receiving assistance from a tax professional or filing using our award-winning online tax product," s ...

Exhibit 99.1 NEWS RELEASE Transcat, Inc. 35 Vantage Point Drive • Rochester • NY • 14624 • Phone: (585) 352-7777 Transcat Reports Strong Fiscal Third Quarter 2026 Financial Results with a Return to High Single-Digit Service Organic Revenue Growth* ROCHESTER, NY, February 3, 2026 – Transcat, Inc. (Nasdaq: TRNS) ("Transcat" or the "Company"), a leader in test measurement, control and calibration, has reported its financial and operational results for its fiscal third quarter ended December 27, 2025 (the "thir ...

Revenue Performance - Q4 2025 revenue decreased by 10% to $646.0 million compared to $721.4 million in Q4 2024[3] - For the twelve months ended December 31, 2025, IAC reported total revenue of $2,393.2 million, a decrease of 8.7% from $2,622.1 million in 2024[36] - In Q4 2025, total revenue was $511.8 million, down 2% from $522.1 million in Q4 2024[30] - Care.com revenue decreased by 9% to $86 million, primarily due to a decline in Enterprise[7] - Digital revenue in Q4 2025 increased by 14% to $354.8 million compared to $310.6 million in Q4 2024[30] - Advertising revenue grew by 9% to $209.9 million in Q4 2025, up from $191.8 million in Q4 2024[30] Profitability and Loss - IAC's net loss improved by 61% to $76.8 million from a loss of $199.0 million in Q4 2024[3] - The net loss attributable to IAC shareholders for the year was $104.0 million, compared to a loss of $539.9 million in 2024[36] - Basic loss per share for the year was $1.46, compared to $6.89 in 2024[36] - Net loss attributable to continuing operations for 2025 was $116.8 million, compared to a loss of $573.2 million in 2024, representing a significant improvement[38] Cash Flow and Financial Position - Free Cash Flow decreased by $132.6 million to $44.8 million for the twelve months ended December 31, 2025[21] - Cash and cash equivalents at the end of the period decreased to $986.8 million from $1,807.3 million, a decline of approximately 45.5%[38] - IAC's long-term debt stood at $1.4 billion, with a weighted average maturity of 6.0 years and a borrowing cost of 7.1%[28] - Total current liabilities decreased from $886.2 million in 2024 to $560.9 million in 2025, a reduction of approximately 36.7%[37] Adjusted EBITDA - Adjusted EBITDA for Q4 2025 increased by 29% to $141.6 million compared to $109.9 million in Q4 2024[3] - For the three months ended December 31, 2025, total Adjusted EBITDA was $141.6 million, compared to $109.9 million for the same period in 2024, representing a 28.9% increase[44] - For the twelve months ended December 31, 2025, total Adjusted EBITDA was $273.0 million, compared to $231.8 million for the same period in 2024, marking an increase of 17.7%[45] - The Digital segment's Adjusted EBITDA for the twelve months ended December 31, 2025, was $307.2 million, up from $289.4 million in 2024, which is a growth of 6.1%[45] - Care.com reported an Adjusted EBITDA of $18.6 million for the three months ended December 31, 2025, compared to $7.9 million in the same period of 2024, indicating a significant increase of 135.4%[44] - The Corporate segment reported an Adjusted EBITDA loss of $113.4 million for the twelve months ended December 31, 2025, compared to a loss of $90.3 million in 2024, indicating a deterioration of 25.6%[45] Strategic Initiatives and Outlook - The company expects total adjusted EBITDA for FY 2026 to be between $260 million and $335 million, with People Inc. contributing $310 million to $340 million[40] - Care.com is projected to return to revenue growth in 2026, indicating a positive outlook for this segment[41] - Corporate expenses are expected to exceed Print Adjusted EBITDA by $15 million due to estimated Google litigation expenses[41] - The company will no longer provide quarterly earnings guidance, focusing instead on long-term strategic priorities[39] Investments and Share Repurchase - IAC repurchased 1.0 million shares for $37 million in Q4 2025, totaling 8.2 million shares repurchased for $337 million over the past year[7] - The company repurchased 1.0 million common shares for $37.0 million between November 1, 2025, and February 2, 2026[26] - IAC's investment in MGM now totals 65.8 million shares, valued at $2.2 billion as of February 2, 2026[17] Challenges and Risks - IAC's future financial performance and business prospects are subject to various risks, including competition from AI technology and unstable market conditions[66] - The company faces challenges related to advertising spending levels and consumer confidence[66] - IAC's ability to market its products effectively and maintain relationships with key partners is critical for its success[66] - The company is committed to protecting user data and ensuring the integrity of its systems against cyber threats[66] Company Overview - IAC is focused on building companies and has evolved into 10 independent, publicly traded companies over nearly three decades[67] - The company holds strategic equity positions in MGM Resorts International and Turo Inc[67] - IAC emphasizes financially-disciplined opportunism as a core principle in its operations[67] - The company is guided by curiosity and a desire to invent or acquire new products and brands[67] - IAC's businesses include category leaders such as People Inc. and Care.com[67] - The company is headquartered in New York City[67]

FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 27, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from ____ to ____ Commission File Number 0-17795 CIRRUS LOGIC, INC. (Exact name of registrant as specified in its charter) | Delaware | | | 77-0024818 | | --- | --- | --- | - ...

Table of Contents ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☑ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended: December 27, 2025 or For the transition period from to Commission File Number: 000-03905 TRANSCAT, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring this shell company report ________ For the transition period from __________ to __________ Commission file number 001-42751 Mega Fortune Company Limited OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended September 30, 2025 OR ☐ TRANSITIONAL REP ...

Exhibit 99.1 Aytu BioPharma Reports Fiscal 2026 Second Quarter Operational and Financial Results Total net revenue of $15.2 million Adjusted EBITDA1 of $(0.8) million, which includes EXXUA launch investments $30.0 million cash balance at December 31, 2025 Company launched EXXUA™ (gepirone) extended-release tablets ("EXXUA") in December 2025 as the centerpiece of its commercial efforts as it enters the over $22 billion United States prescription major depressive disorder ("MDD") market Company to host confer ...

Emerson Reports First Quarter 2026 Results; Updates 2026 Outlook ST. LOUIS (February 3, 2026) - Emerson (NYSE: EMR) today reported results for its first quarter ended December 31, 2025 and updated its full year outlook for fiscal 2026. Emerson also declared a quarterly cash dividend of $0.555 per share of common stock payable March 10, 2026 to stockholders of record on February 13, 2026. | (dollars in millions, except per share) | 2025 Q1 | 2026 Q1 | Change | | --- | --- | --- | --- | | 1 Underlying Orders ...

Investment Portfolio - As of December 31, 2025, the investment portfolio consisted of 71.0% in debt investments and 29.0% in equity investments, at cost[166]. - From inception through December 31, 2025, the company has invested approximately $2.2 billion in 66 companies, excluding syndicated loans[171]. - As of December 31, 2025, the company had equity investments in 29 portfolio companies with a total cost basis of $1.1 billion, up from 26 companies with a cost basis of $1.0 billion in 2024[222]. - The total investment portfolio at fair value increased to $1,222.8 million as of December 31, 2025, up from $1,072.2 million in 2024, representing a growth of approximately 14%[223]. - The entire investment portfolio was fair valued at 115.5% of cost as of December 31, 2025[200]. Financial Performance - The company generated $353.4 million in net realized gains and $45.4 million in other income from exiting 33 portfolio companies, totaling an increase of $398.8 million to net assets[173]. - Total investment income for the three months ended December 31, 2025, increased by $3.7 million, or 17.3%, to $25.1 million compared to the prior year[182]. - Interest income rose by $2.3 million, or 11.2%, to $22.8 million for the same period, driven by an increase in the weighted-average principal balance of the interest-bearing investment portfolio[183]. - Net investment loss income was $(6.5) million for the three months ended December 31, 2025, a decrease of $7.7 million compared to the prior year[181]. - Net unrealized appreciation increased by $32.9 million, or 88.1%, to $70.2 million for the three months ended December 31, 2025[181]. - Total investment income increased by $7.8 million, or 11.8%, for the nine months ended December 31, 2025, compared to the prior year period[202]. - Net investment income decreased by $14.0 million, or 67.1%, for the nine months ended December 31, 2025[201]. - The net increase in net assets resulting from operations was $102.4 million for the nine months ended December 31, 2025, compared to $47.4 million in the prior year[201]. Expenses and Fees - Total expenses, net of credits from the Adviser, increased by $11.4 million, or 56.2%, to $31.6 million for the three months ended December 31, 2025[189]. - The capital gains-based incentive fee for the three months ended December 31, 2025, was $14.7 million, compared to $7.5 million in the prior year[190]. - Total expenses, net of credits from the Adviser, increased by $21.8 million, or 48.1%, during the nine months ended December 31, 2025[208]. - Interest expense rose by $8.4 million, or 43.4%, during the nine months ended December 31, 2025, primarily due to new debt issuances and increased borrowings[210]. - The capital gains-based incentive fee for the nine months ended December 31, 2025, was $19.4 million, up from $5.3 million in the same period of 2024[209]. Debt and Financing - The company issued the 6.875% 2028 Notes for gross proceeds of $60.0 million and sold 2,984,586 shares of common stock for approximately $42.1 million during the nine months ended December 31, 2025[174]. - The company completed a public offering of the 5.00% 2026 Notes with an aggregate principal amount of $127.9 million, resulting in net proceeds of approximately $123.8 million after costs[241]. - The 4.875% 2028 Notes had an aggregate principal amount of $134.6 million, yielding net proceeds of approximately $131.3 million after costs[244]. - The 8.00% 2028 Notes were issued with an aggregate principal amount of $74.8 million, with a loss on extinguishment of debt recorded at $1.3 million[247]. - The 7.875% 2030 Notes had an aggregate principal amount of $126.5 million, resulting in net proceeds of approximately $122.4 million after costs[248]. - As of December 31, 2025, the company had $128.6 million of borrowings outstanding under its Credit Facility, with a maximum facility size of $300.0 million[236][238]. - The company anticipates issuing equity securities to obtain additional capital in the future, with a closing market price of $13.97 per share as of December 31, 2025, representing a 6.6% discount to its NAV per share of $14.95[235]. Risk Management - The company is exposed to interest rate risk due to borrowing for investments, with net investment income dependent on the difference between borrowing rates and investment rates[265]. - The company has no fixed-rate loans in its portfolio as of December 31, 2025, indicating a complete reliance on variable-rate loans[266]. - The company targets approximately 90% of its loan portfolio to be at variable rates, with all variable-rate loans linked to the current 30-day SOFR rate as of March 31, 2025[266]. - A hypothetical analysis indicates that a 150 basis point increase in interest rates could result in a net increase of $4.494 million in net assets from operations[268]. - The company may use interest rate risk management techniques, including hedging activities, to limit exposure to interest rate fluctuations[265]. - Risks associated with foreign operations include fluctuations in foreign currency exchange rates and potential tariffs, affecting some portfolio companies[269]. Cash Distributions - The company declared a total cash distribution of $0.24 per common share for the quarter ending March 31, 2026[179]. - The company declared monthly cash distributions of $0.08 per common share for nine months from April to December 2025, along with a supplemental distribution of $0.54 per common share in June 2025[226]. - The company has a policy to distribute up to 100% of its Investment Company Taxable Income to stockholders[262]. - The company intends to maintain its qualification as a RIC under Subchapter M of the Code, which requires distributing at least 90% of its Investment Company Taxable Income to stockholders[262].